Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Lanzillo

Showing results (191-200 of 210) with videos related to

Pageof 21
Sort By:
Journal of Neurology|February 15, 2022
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective studyAntonio Riccardo Buonomo, Giulio Viceconte, Massimiliano Calabrese, et al.
Multiple Sclerosis and Related Disorders|February 20, 2026
Abuse in individuals with multiple sclerosis: the SocialMS Italian studyMarta Ponzano, Alessio Signori, Irene Schiavetti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 6, 2024
Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesisGiacomo Greco, Mario Risi, Stefano Masciocchi, et al.
CNS Drugs|May 29, 2025
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational StudyGiovanni Novi, Francesca Bovis, Chiara Sciolla, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 27, 2020
Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter studyFrancesco Patti, Clara Grazia Chisari, Claudio Solaro, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 15, 2020
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre studyClara Grazia Chisari, Claudio Solaro, Pasquale Annunziata, et al.
Neurology|November 3, 2017
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter studyAlice Laroni, Alessio Signori, Giorgia T Maniscalco, et al.
Neurology and Therapy|February 18, 2026
Reducing Early-Life Smoke Exposure as a Preventive Strategy for Pediatric Multiple Sclerosis: Results from the PEDIGREE StudySilvy Pilotto, Angelo Ghezzi, Stefania Maria Bova, et al.
Neurology and Therapy|May 24, 2026
Reduced Childhood Outdoor Exposure Raises Pediatric Multiple Sclerosis (PedMS) RiskSilvy Pilotto, Angelo Ghezzi, Stefania Maria Bova, et al.
Multiple Sclerosis and Related Disorders|March 26, 2020
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian studyGiorgia T Maniscalco, Francesco Saccà, Roberta Lanzillo, et al.
Pageof 21

Showing results (191-200 of 210) with videos related to

Sort By:
Pageof 21
Journal of Neurology|February 15, 2022
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective studyAntonio Riccardo Buonomo, Giulio Viceconte, Massimiliano Calabrese, et al.
Multiple Sclerosis and Related Disorders|February 20, 2026
Abuse in individuals with multiple sclerosis: the SocialMS Italian studyMarta Ponzano, Alessio Signori, Irene Schiavetti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 6, 2024
Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesisGiacomo Greco, Mario Risi, Stefano Masciocchi, et al.
CNS Drugs|May 29, 2025
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational StudyGiovanni Novi, Francesca Bovis, Chiara Sciolla, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 27, 2020
Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter studyFrancesco Patti, Clara Grazia Chisari, Claudio Solaro, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 15, 2020
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre studyClara Grazia Chisari, Claudio Solaro, Pasquale Annunziata, et al.
Neurology|November 3, 2017
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter studyAlice Laroni, Alessio Signori, Giorgia T Maniscalco, et al.
Neurology and Therapy|February 18, 2026
Reducing Early-Life Smoke Exposure as a Preventive Strategy for Pediatric Multiple Sclerosis: Results from the PEDIGREE StudySilvy Pilotto, Angelo Ghezzi, Stefania Maria Bova, et al.
Neurology and Therapy|May 24, 2026
Reduced Childhood Outdoor Exposure Raises Pediatric Multiple Sclerosis (PedMS) RiskSilvy Pilotto, Angelo Ghezzi, Stefania Maria Bova, et al.
Multiple Sclerosis and Related Disorders|March 26, 2020
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian studyGiorgia T Maniscalco, Francesco Saccà, Roberta Lanzillo, et al.
Pageof 21